Tumor Suppressor Par-4 Regulates Complement Factor C3 and Obesity

Area of Science:

• Molecular biology
• Metabolic research
• Obesity research

Background:

• Prostate apoptosis response-4 (Par-4) is a known tumor suppressor.
• The physiological role of Par-4 in metabolic processes, particularly obesity, is not well understood.

Purpose of the Study:

• To investigate the physiological function of Par-4 in the context of obesity.
• To elucidate the molecular mechanisms by which Par-4 influences fat metabolism and adipocyte function.

Main Methods:

• Generation and analysis of conventional and adipocyte-specific Par-4 knockout mouse models.
• Investigation of molecular pathways involving mdm2, p53, and complement factor c3.
• Correlation analysis of Par-4 expression in obese human subjects and longitudinal obesity risk assessment.

Main Results:

• Par-4 knockout mice (conventional and adipocyte-specific) developed obesity on a standard diet, with increased fat absorption and storage.
• Par-4 deficiency led to mdm2 downregulation, p53 activation, and upregulation of the p53-regulated gene c3 in adipocytes.
• Re-expression of Par-4 or deletion of c3 reversed the obese phenotype in mice.
• Obese humans exhibited lower Par-4 expression, and low baseline Par-4 levels predicted future obesity development.

Conclusions:

• Par-4 acts as a suppressor of obesity by regulating fat storage in adipocytes.
• The Par-4/p53/c3 pathway is a critical regulator of adipocyte function and systemic energy balance.
• Par-4 deficiency is a risk factor for obesity in humans.